It’s all about absorption
Immunidiol includes a patented award winning absorption platform that allows for better, easier and more potent bioavailability.
“In clinical trials Immunidiol demonstrated superior strengthening of the immune system with immune modulating functions that improve one’s ability to adapt to stress. Modulating immune functions is a critical component to health; it’s the ability of your immune system to modify, adjust, or regulate your immune response to a desired level”.
Dr. Harald Newball M.D. FACP, FCCP, FAAAAI*
*Harvard Medical School Trained Physician
QUICK FACTS
- Improves cellular and hormonal immunity.
- Increases activity of phagocytes (cells that protect the body) and elevates levels of cellular factors for enhanced immune response
- Potent triggering agent of the immune defense system.
- Increases the responsiveness of lymphocytes in the elderly.
- Immunomodulatory activities.
- Clinically demonstrated to suppress the growth of ovarian, colon, skin and prostate cancer cells.
- The active components have been shown to have anti-tumor, anti-stress, and antioxidant activities.
- Increases the efficacy of chemotherapy and reduces the side effects.
- Clinically shown to substantially prolong life span within vivo research.
- Demonstrates in clinical trials to improve the ability of stress-adaptation.
- 100% natural
These statements have not been evaluated by Health Canada or the United States Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Please note that the physiological activity of Immunidiol described herein is supported by numerous referenced scientific studies. Marketers of finished products containing Immunidiol are responsible for determining whether claims made for such products are in compliance with the laws and regulations of the country in which the products will be marketed.
Immunidiol (US Patent 8148354 B2, additional patents pending) and Proneurol (US Patent 8148354 B2, additional patents pending) are registered trademarks of Nuumara Holdings Canada Inc.
Please note that the physiological activity of Immunidiol described herein is supported by numerous referenced scientific studies. Marketers of finished products containing Immunidiol are responsible for determining whether claims made for such products are in compliance with the laws and regulations of the country in which the products will be marketed.
Immunidiol (US Patent 8148354 B2, additional patents pending) and Proneurol (US Patent 8148354 B2, additional patents pending) are registered trademarks of Nuumara Holdings Canada Inc.
Nuumara Holdings Canada Inc. ©2017 ALL RIGHTS RESERVED